Total Payments
$7,746
2024 Payments
$999.64
Companies
31
Transactions
376
Medicare Patients
13,088
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$7,746 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,746 | 376 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma Inc. | $1,139 | 78 | $0 (2024) |
| ABBVIE INC. | $860.44 | 46 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $592.25 | 29 | $0 (2024) |
| Amgen Inc. | $577.02 | 22 | $0 (2024) |
| Lilly USA, LLC | $457.28 | 21 | $0 (2024) |
| UCB, Inc. | $386.09 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $335.40 | 16 | $0 (2024) |
| Galderma Laboratories, L.P. | $335.28 | 17 | $0 (2024) |
| PFIZER INC. | $313.03 | 14 | $0 (2024) |
| GENZYME CORPORATION | $286.74 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $999.64 | 42 | E.R. Squibb & Sons, L.L.C. ($106.11) |
| 2023 | $1,153 | 49 | AbbVie Inc. ($148.43) |
| 2022 | $1,170 | 52 | LEO Pharma Inc. ($149.84) |
| 2021 | $1,084 | 56 | AbbVie Inc. ($226.51) |
| 2020 | $499.36 | 25 | LEO Pharma Inc. ($128.25) |
| 2019 | $884.01 | 47 | LEO Pharma Inc. ($130.24) |
| 2018 | $886.19 | 47 | LEO Pharma Inc. ($183.23) |
| 2017 | $1,070 | 58 | LEO Pharma Inc. ($243.18) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.51 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $46.04 | General |
| Category: Immunology | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/09/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: ACNE | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.95 | General |
| Category: Immunology | ||||||
| 06/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DERMATOLOGY | ||||||
| 05/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,816 | 5,348 | $1.2M | $327,005 |
| 2022 | 21 | 3,319 | 4,449 | $749,468 | $294,416 |
| 2021 | 23 | 3,260 | 4,553 | $760,501 | $303,970 |
| 2020 | 17 | 2,693 | 3,813 | $627,785 | $224,844 |
Total Patients
13,088
Total Services
18,163
Medicare Billing
$1.2M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,036 | 1,252 | $319,360 | $84,886 | 26.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 665 | 882 | $290,472 | $82,852 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 450 | 521 | $176,365 | $51,824 | 29.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 452 | 552 | $111,588 | $24,029 | 21.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 316 | 373 | $60,840 | $15,895 | 26.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 179 | 193 | $54,120 | $15,598 | 28.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 31 | 34 | $29,580 | $9,457 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $34,020 | $8,991 | 26.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 248 | 1,066 | $25,584 | $6,290 | 24.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 23 | 24 | $16,335 | $5,412 | 33.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 51 | 52 | $16,800 | $5,184 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $11,180 | $3,306 | 29.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $10,550 | $2,962 | 28.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 58 | 68 | $11,400 | $2,592 | 22.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $13,142 | $2,002 | 15.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 35 | 35 | $7,690 | $1,705 | 22.2% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 15 | 17 | $4,780 | $1,224 | 25.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $4,232 | $1,115 | 26.4% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $6,384 | $1,020 | 16.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 13 | $1,644 | $600.99 | 36.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 55 | 74 | $222.00 | $58.81 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 978 | 1,199 | $179,850 | $83,657 | 46.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 571 | 777 | $195,804 | $74,455 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 393 | 434 | $93,310 | $42,924 | 46.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 345 | 424 | $72,928 | $18,654 | 25.6% |
About Dr. Robin Travers, MD
Dr. Robin Travers, MD is a Dermatology healthcare provider based in Chestnut Hill, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578532388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Travers, MD has received a total of $7,746 in payments from pharmaceutical and medical device companies, with $999.64 received in 2024. These payments were reported across 376 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,746).
As a Medicare-enrolled provider, Travers has provided services to 13,088 Medicare beneficiaries, totaling 18,163 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Chestnut Hill, MA
- Active Since 03/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1578532388
Products in Payments
- ENSTILAR (Drug) $902.70
- COSENTYX (Biological) $488.15
- TALTZ (Drug) $457.28
- Otezla (Drug) $424.71
- DUPIXENT (Biological) $360.27
- EUCRISA (Drug) $313.03
- SKYRIZI (Biological) $300.94
- Enbrel (Biological) $263.08
- Cimzia (Drug) $253.48
- ADBRY (Biological) $236.77
- TREMFYA (Drug) $232.10
- OPZELURA (Drug) $226.98
- RINVOQ (Biological) $198.32
- Sotyktu (Drug) $191.93
- Humira (Biological) $183.04
- DORYX (Drug) $141.40
- EPIDUO FORTE (Drug) $139.33
- Xolair (Biological) $135.12
- VTAMA (Drug) $135.10
- Bimzelx (Biological) $132.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chestnut Hill
Jeffrey Sobell, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Michael Kaminer, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Jeffrey Dover, Md, MD
Dermatology — Payments: $241,174
Dermatology $241,174
Kenneth Arndt, Md, MD
Dermatology — Payments: $38,802
Dermatology $38,802
Dr. Brooke Sikora, M.d, M.D
Dermatology — Payments: $26,039
Dermatology $26,039
Thomas Rohrer, M.d, M.D
Dermatology — Payments: $12,331
Dermatology $12,331